99 related articles for article (PubMed ID: 9785295)
1. Disease progression and cost of insulin dependent diabetes mellitus: development and application of a simulation model.
Tomar RH; Lee S; Wu SY; Klein R; Klein BE; Moss SE; Fryback DG; Tollios JL; Sainfort F
J Soc Health Syst; 1998; 5(4):24-37. PubMed ID: 9785295
[TBL] [Abstract][Full Text] [Related]
2. The CORE Diabetes Model: Projecting long-term clinical outcomes, costs and cost-effectiveness of interventions in diabetes mellitus (types 1 and 2) to support clinical and reimbursement decision-making.
Palmer AJ; Roze S; Valentine WJ; Minshall ME; Foos V; Lurati FM; Lammert M; Spinas GA
Curr Med Res Opin; 2004 Aug; 20 Suppl 1():S5-26. PubMed ID: 15324513
[TBL] [Abstract][Full Text] [Related]
3. A comparison of the study populations in the Diabetes Control and Complications Trial and the Wisconsin Epidemiologic Study of Diabetic Retinopathy.
Klein R; Moss S
Arch Intern Med; 1995 Apr; 155(7):745-54. PubMed ID: 7695463
[TBL] [Abstract][Full Text] [Related]
4. A simulation model of the cost of the incidence of IDDM in Spain.
Hart WM; Espinosa C; Rovira J
Diabetologia; 1997 Mar; 40(3):311-8. PubMed ID: 9084970
[TBL] [Abstract][Full Text] [Related]
5. The cost-effectiveness of treatment with lamivudine and zidovudine compared with zidovudine alone: a comparison of Markov model and trial data estimates.
Mauskopf J; Lacey L; Kempel A; Simpson K
Am J Manag Care; 1998 Jul; 4(7):1004-12. PubMed ID: 10181990
[TBL] [Abstract][Full Text] [Related]
6. Cross-sectional analysis of adult diabetes type 1 and type 2 patients with diabetic microvascular complications from a German retrospective observational study.
Happich M; Breitscheidel L; Meisinger C; Ulbig M; Falkenstein P; Benter U; Watkins J
Curr Med Res Opin; 2007 Jun; 23(6):1367-74. PubMed ID: 17559744
[TBL] [Abstract][Full Text] [Related]
7. The C825T polymorphism in the G-protein beta3 subunit gene and diabetic complications in IDDM patients.
Shcherbak NS; Schwartz EI
J Hum Genet; 2001; 46(4):188-91. PubMed ID: 11322658
[TBL] [Abstract][Full Text] [Related]
8. Analysis of censored and incomplete survival data using flowgraph models.
Yau CL; Huzurbazar AV
Stat Med; 2002 Dec; 21(23):3727-43. PubMed ID: 12436467
[TBL] [Abstract][Full Text] [Related]
9. Empiric investigation on direct costs-of-illness and healthcare utilization of Medicaid patients with diabetes mellitus.
Guo JJ; Gibson JT; Gropper DM; Oswald SL; Barker KN
Am J Manag Care; 1998 Oct; 4(10):1433-46. PubMed ID: 10338736
[TBL] [Abstract][Full Text] [Related]
10. Retinopathy in patients with diabetic ophthalmoplegia.
Trigler L; Siatkowski RM; Oster AS; Feuer WJ; Betts CL; Glaser JS; Schatz NJ; Farris BK; Flynn HW
Ophthalmology; 2003 Aug; 110(8):1545-50. PubMed ID: 12917170
[TBL] [Abstract][Full Text] [Related]
11. Healthcare charges and utilization associated with diabetic neuropathy: impact of Type 1 diabetes and presence of other diabetes-related complications and comorbidities.
Zhao Y; Ye W; Boye KS; Holcombe JH; Swindle R
Diabet Med; 2009 Jan; 26(1):61-9. PubMed ID: 19125762
[TBL] [Abstract][Full Text] [Related]
12. [Effect of lisinopril on progression of retinopathy and microalbuminuria in normotensive subjects with insulin-dependent diabetes mellitus].
Sjølie AK; Chaturvedi N; Fuller J
Ugeskr Laeger; 1999 Feb; 161(7):949-52. PubMed ID: 10051804
[TBL] [Abstract][Full Text] [Related]
13. Advances in therapy for insulin-dependent diabetes mellitus.
Mintz DH
Med Sect Proc; 1993; ():157-69. PubMed ID: 8078868
[No Abstract] [Full Text] [Related]
14. [Insulin-dependent diabetes in the county of Funen 1970-2020. An epidemiological description].
Green A; Sjølie AK; Eshøj O
Ugeskr Laeger; 1998 Feb; 160(8):1163-7. PubMed ID: 9492627
[TBL] [Abstract][Full Text] [Related]
15. Development and application of a model to estimate the impact of type 1 diabetes on health-related quality of life.
Wu SY; Sainfort F; Tomar RH; Tollios JL; Fryback DG; Klein R; Klein BE
Diabetes Care; 1998 May; 21(5):725-31. PubMed ID: 9589231
[TBL] [Abstract][Full Text] [Related]
16. Relation of glycemic control to diabetic microvascular complications in diabetes mellitus.
Klein R; Klein BE; Moss SE
Ann Intern Med; 1996 Jan; 124(1 Pt 2):90-6. PubMed ID: 8554220
[TBL] [Abstract][Full Text] [Related]
17. Severe hypoglycemia and smoking in a long-term type 1 diabetic population: Wisconsin Epidemiologic Study of Diabetic Retinopathy.
Hirai FE; Moss SE; Klein BE; Klein R
Diabetes Care; 2007 Jun; 30(6):1437-41. PubMed ID: 17372156
[TBL] [Abstract][Full Text] [Related]
18. A cost analysis of community screening for diabetes in the central Wisconsin Medicare population (results from the MetaStar pilot project in Wausau).
Lee DS; Remington P; Madagame J; Blustein J
WMJ; 2000 Jun; 99(3):39-43. PubMed ID: 10927980
[TBL] [Abstract][Full Text] [Related]
19. Cardiovascular disease, mortality, and retinal microvascular characteristics in type 1 diabetes: Wisconsin epidemiologic study of diabetic retinopathy.
Klein BE; Klein R; McBride PE; Cruickshanks KJ; Palta M; Knudtson MD; Moss SE; Reinke JO
Arch Intern Med; 2004 Sep; 164(17):1917-24. PubMed ID: 15451768
[TBL] [Abstract][Full Text] [Related]
20. [Polymorphism of aldose reductase gene and susceptibility to retinopathy and nephropathy in Caucasians with type 1 diabetes].
Fanelli A; Hadjadj S; Gallois Y; Fumeron F; Betoule D; Grandchamp B; Marre M
Arch Mal Coeur Vaiss; 2002; 95(7-8):701-8. PubMed ID: 12365083
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
